FDA Briefing Document: BPC-157-Related Bulk Drug Substances (PCAC July 2026)
FDA's background package for the Pharmacy Compounding Advisory Committee discussion of BPC-157 free base and BPC-157 acetate. It identifies identity/characterization concerns and safety issues and notes no final determination will be made at the meeting.
Not legal or medical advice.
This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.
U.S. Food and Drug AdministrationAdvisory committee briefingAdvisory
- Docket / Citation
- FDA-2026-N-XXXX
- Published
- 2026-05-11